Steven Hite and Don Boudria in support of Bill C-284
For the prevention and treatment of eye disease
OTTAWA, ON (April 4, 2023) — Steven Hite, Chief Executive Officer of Nova Oculus, met with Nova’s public affairs and government relations advisors including Don Boudria, former member of the House of Commons, during a visit to Ottawa to discuss Nova’s ongoing support for Bill C-284 and the further planning for Nova’s medical device market entry.
A main proponent of Bill C-284, Mr. Boudria served in the House of Commons of Canada from 1984 to 2005 and was a cabinet minister in the government of Jean Chrétien.
The enactment of the bill provides for the development of a national strategy to support the prevention and treatment of eye disease to ensure better health outcomes for Canadians. It also designates the month of February as “Age-Related Macular Degeneration Month”.
ABOUT NOVA OCULUS III
NOVA OCULUS III is the name of our pioneering new medical device engineered and developed to treat the dry form of Age-Related Macular Degeneration. This medical device has been approved by Health Canada. Our device has also been certified as complying with the quality management standard set by the International Organization of Standardization (ISO) and the electrical safety standard set by the International Electrotechnical Commission (IEC). These certifications are critical to future global regulatory approvals for the Nova Oculus medical device.